ALFA FinderBSE filing, BSE: 544629. Summary written from the filing by ALFA Finder's alert engine.
Ravelcare Ltd: key numbers
- Share price
- ₹98.00
- Market cap
- ₹67.22 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 13.0×Sector 40.7×
- Promoter holding
- 72.94%
- FII holding
- 1.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →Ravelcare Investor Presentation: Key Takeaways
H1 FY27 revenue ₹15.15 Cr (+20.7% vs H2 FY26), PAT ₹3.84 Cr (+96.6% vs H2, +19.8% vs H1 FY26), EBITDA margin 29.6%. Debt-free with ₹26.6 Cr cash; PRO range live, skincare due December 2026.
Ravelcare Results Update
Ravelcare's H1 FY27 unaudited profit after tax nearly doubled to ₹3.84 crore on 20.7% revenue growth. A personalised skincare range is slated for launch by December 2026.
Ravelcare H1 FY27 Results: Net Profit ₹3.8 Cr, Up 18.7% YoY
Ravelcare Limited's board approved unaudited standalone results for the half year ended September 2026. The results carry a limited review report from statutory auditors.
- Key figure
- Net profit ₹3.8 Cr · +18.7% YoY
Ravelcare Board Meeting Date
Ravelcare will meet on November 12, 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after the results declaration.
Ravelcare Other Announcement
Ravelcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine compliance disclosure.
Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.
Other other announcement announcements
All →Deccan Gold Mines Other Announcement
Deccan Gold Mines filed a monitoring agency report for the quarter ended 30 September 2026 on its Rs 314.70 crore rights issue. The report shows no deviation from the issue objects.
CSM Technologies Other Announcement
CSM Technologies filed its IPO Monitoring Agency Report for the quarter ended September 30, 2026. The report shows no deviation from objects but flags fund co-mingling.
Astal Laboratories Other Announcement
Astal Laboratories filed its Reg 32 statement for the quarter ended 30 September 2026, confirming no deviation in use of funds. The Rs 33.99 Lakh preferential issue proceeds were fully utilised as originally disclosed.
360 One Wam Other Announcement
Designated person Mayur Patel sold 61,365 equity shares of 360 ONE WAM via market sale between 6 and 11 November 2026. The sale value is Rs.7.05 Crore.
- Value
- ₹7.05 Cr
Aegeus Technologies Other Announcement
Aegeus Technologies filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026. It reports IPO proceeds utilised per stated objects, with no deviation.
Yuvraaj Hygiene Products Other Announcement
Yuvraaj Hygiene is exempt from Regulation 23(9) related party filings for half year ended September 30, 2026. Paid-up capital and net worth fall below Regulation 15(2) thresholds.